Renalys Pharma, Inc. reported the dosing of the initial participant in its phase III clinical trial of sparsentan for IgA nephropathy treatment in Japan. Renalys submitted an Investigational New Drug (IND) Application for sparsentan to the...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has given the green light for the medication vibegron (Obgemsa) to address symptoms of overactive bladder (OAB) syndrome in adult patients. Indications might consist of a sudden...
The increasing prevalence of neurological disorders is fueling market expansion, as there is a shift towards manufacturing radiopharmaceuticals utilizing cyclotron technology. Yet, challenges arise due to issues with preparing and distributing...
Miltenyi Biotec, a prominent provider of biomedical solutions worldwide, has signed a Letter of Intent with the Translational Health Science and Technology Institute (THSTI) in New Delhi, an autonomous institute under the Department of...
Lupin, a global pharmaceutical company, announced a licensing and supply agreement with Huons, a top Korean pharmaceutical company to enhance their ophthalmology offerings. The focus of the agreement is on registering and marketing Cyclosporine...
Full-Life Technologies, a globally integrated radiotherapeutics company with facilities in Belgium, Germany, and China, has signed a $571.5 million license agreement with SK Biopharmaceuticals, a worldwide biotech company, for exclusive global...
.jpg)
